Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sahar Fanoudi, Mohaddeseh Sadat Alavi, Gholamreza Karimi & Hossein Hosseinzadeh. (2020) Milk thistle (Silybum Marianum) as an antidote or a protective agent against natural or chemical toxicities: a review. Drug and Chemical Toxicology 43:3, pages 240-254.
Read now
Read now
Francis J Dumont. (2005) Interleukin-2 family cytokines: potential for therapeutic immmunoregulation. Expert Opinion on Therapeutic Patents 15:5, pages 521-554.
Read now
Read now
Anamaria Jorga & Atholl Johnston. (2005) Novel therapies in transplantation. Expert Opinion on Investigational Drugs 14:3, pages 295-304.
Read now
Read now
Articles from other publishers (51)
Kin Man Au, Justin E. Wilson, Jenny P.-Y. Ting & Andrew Z. Wang. (2023) An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis. Nature Biomedical Engineering.
Crossref
Crossref
Armin Ghomeshi, Boris Yang & Thomas A. Masterson. (2023) The adverse effects of commonly used medications on male fertility: a comprehensive review. F&S Reviews.
Crossref
Crossref
Maan T. Khayat, Khadijah A. Mohammad, Abdelsattar M. Omar, Gamal A. Mohamed & Sabrin R. M. Ibrahim. (2022) Fungal Bergamotane Sesquiterpenoids—Potential Metabolites: Sources, Bioactivities, and Biosynthesis. Marine Drugs 20:12, pages 771.
Crossref
Crossref
Giovanna Castoldi, Raffaella Carletti, Silvia Ippolito, Massimiliano Colzani, Francesca Barzaghi, Andrea Stella, Gianpaolo Zerbini, Gianluca Perseghin, Giovanni Zatti & Cira R. T. di Gioia. (2021) Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy. Acta Diabetologica 58:8, pages 1059-1070.
Crossref
Crossref
Hsiang‐i Tsai, Xiaobin Zeng, Longshan Liu, Shengchang Xin, Yingyi Wu, Zhanxue Xu, Huanxi Zhang, Gan Liu, Zirong Bi, Dandan Su, Min Yang, Yijing Tao, Changxi Wang, Jing Zhao, John E Eriksson, Wenbin Deng, Fang Cheng & Hongbo Chen. (2021) NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development. EMBO Molecular Medicine 13:3.
Crossref
Crossref
Jinsoo Rhu. (2020) History of organ transplantation and the development of key immunosuppressants. Journal of the Korean Medical Association 63:5, pages 241-250.
Crossref
Crossref
Zhong-shu Kuang, Yi-lin Yang, Wei Wei, Jian-li Wang, Xiang-yu Long, Ke-yong Li, Chao-yang Tong, Zhan Sun & Zhen-ju Song. (2020) Clinical characteristics and prognosis of community-acquired pneumonia in autoimmune disease-induced immunocompromised host: A retrospective observational study. World Journal of Emergency Medicine 11:3, pages 145.
Crossref
Crossref
Eileen T. Chambers & Allan D. Kirk. 2020. Kidney Transplantation - Principles and Practice. Kidney Transplantation - Principles and Practice
283
312
.
Fabrizio Pertusati, Michaela Serpi & Elisa Pileggi. 2019. Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals. Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals
141
180
.
Anshika Singh & Sudhir Krishna. 2019. Bioactive Natural Products for the Management of Cancer: from Bench to Bedside. Bioactive Natural Products for the Management of Cancer: from Bench to Bedside
139
166
.
Marwa Y. Sallam, Sahar M. El-Gowilly, Abdel-Galil A. Abdel-Galil & Mahmoud M. El-Mas. (2018)
Activation of central GABA
B
receptors offsets the cyclosporine counteraction of endotoxic cardiovascular outcomes in conscious rats
. Fundamental & Clinical Pharmacology 32:5, pages 485-498.
Crossref
Crossref
Safaa H. Hammoud, Sahar Alkhansa, Neamah Mahjoub, Amal G. Omar, Mahmoud M. El-Mas & Assaad A. Eid. (2018) Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity. American Journal of Physiology-Renal Physiology 315:3, pages F572-F582.
Crossref
Crossref
Hany M. El-Bassossy & Basma G. Eid. (2018) Cyclosporine A exhibits gender-specific nephrotoxicity in rats: Effect on renal tissue inflammation. Biochemical and Biophysical Research Communications 495:1, pages 468-472.
Crossref
Crossref
Hany M. El-Bassossy, Zuhier Awan & Mahmoud M. El-Mas. (2017) Perinatal ciclosporin A exposure elicits sex-related cardiac dysfunction and inflammation in the rat progeny. Toxicology Letters 281, pages 35-43.
Crossref
Crossref
Safaa H. Hammoud, Amal G. Omar, Assaad A. Eid & Mahmoud M. El-Mas. (2017) CYP4A/CYP2C modulation of the interaction of calcium channel blockers with cyclosporine on EDHF-mediated renal vasodilations in rats. Toxicology and Applied Pharmacology 334, pages 110-119.
Crossref
Crossref
DH El-Kashef, AE El-Kenawi, GM Suddek & HA Salem. (2016) Allicin ameliorates kidney function and urinary bladder sensitivity in cyclosporine A-treated rats. Human & Experimental Toxicology 36:7, pages 681-691.
Crossref
Crossref
Na-na Ping, Yan-ni Mi, Dong-zheng Liu, Sai Zhang, Jing-guo Chen & Yong-xiao Cao. (2016) H2S Prevents Cyclosporine A-Induced Vasomotor Alteration in Rats. Cardiovascular Toxicology 17:3, pages 287-296.
Crossref
Crossref
Hany M. El-Bassossy, Zainy M. Banjar & Mahmoud M. El-Mas. (2017) The inflammatory state provokes sexual dimorphism in left ventricular and electrocardiographic effects of chronic cyclosporine in rats. Scientific Reports 7:1.
Crossref
Crossref
Suneet Kaur, Gautam Srivastava, Amar Nath Sharma & Ravinder S Jolly. (2015) Novel immunosuppressive agent caerulomycin A exerts its effect by depleting cellular iron content. British Journal of Pharmacology 172:9, pages 2286-2299.
Crossref
Crossref
Marjan Gharagozloo, Slawomir Majewski & Marianna Foldvari. (2015) Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction. Nanomedicine: Nanotechnology, Biology and Medicine 11:4, pages 1003-1018.
Crossref
Crossref
Hanan M. El-Gowelli, Maged W. Helmy, Rabab M. Ali & Mahmoud M. El-Mas. (2014) Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-?1/IL-2/COX-2/endothelin ETB receptor cascade. Toxicology and Applied Pharmacology 275:2, pages 88-95.
Crossref
Crossref
Allan D. Kirk. 2014. Kidney Transplantation–Principles and Practice. Kidney Transplantation–Principles and Practice
287
313
.
Isao Matsui-Yuasa & Akiko Kojima-Yuasa. 2013. Tea in Health and Disease Prevention. Tea in Health and Disease Prevention
1299
1307
.
Miryam Andrea Hortua Triana, My-Hang Huynh, Manuel F. Garavito, Barbara A. Fox, David J. Bzik, Vern B. Carruthers, Monika L?ffler & Barbara H. Zimmermann. (2012) Biochemical and molecular characterization of the pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase from Toxoplasma gondii. Molecular and Biochemical Parasitology 184:2, pages 71-81.
Crossref
Crossref
Gijs G. Baaten, Ronald B. Geskus, Joan A. Kint, Anna H.E. Roukens, Gerard J. Sonder & Anneke van den Hoek. (2011) Symptoms of Infectious Diseases in Immunocompromised Travelers: A Prospective Study With Matched Controls. Journal of Travel Medicine 18:5, pages 318-326.
Crossref
Crossref
R. Jouenne, Ch. Pagnoux & L. Guillevin. 2010. Les Uvéites. Les Uvéites
645
660
.
?lvaro Ter?n, Fernando Casafont, Emilio F?brega, V?ctor Manuel Mart?nez-Taboada, Vicente Rodr?guez-Valverde & Fernando Pons-Romero. (2009) Enfermedad de Still del adulto con desarrollo de insuficiencia hep?tica que precisa trasplante hep?tico. Gastroenterolog?a y Hepatolog?a 32:10, pages 681-686.
Crossref
Crossref
P. S. Rommer, O. Stüve, R. Goertsches, E. Mix & U. K. Zettl. (2008) Monoclonal antibodies in the therapy of multiple sclerosis. Journal of Neurology 255:S6, pages 28-35.
Crossref
Crossref
Sahar M El-Gowilly, Abdel-Rheem M Ghazal, Eman Y Gohar & Mahmoud M El-Mas. (2008) EXACERBATION BY NICOTINE OF THE CYCLOSPORINE A-INDUCED IMPAIRMENT OF β-ADRENOCEPTOR-MEDIATED RENAL VASODILATION IN RATS. Clinical and Experimental Pharmacology and Physiology 35:10, pages 1164-1171.
Crossref
Crossref
Hugo Bonatti, Jennifer Gillis, Natalie Berger, Walter Mark, Hans-Jorg Kofler, Raimund Margreiter & Bettina Pfausler. (2008) Remission of multiple sclerosis in a patient with insulin dependent diabetes mellitus following combined kidney-pancreas transplantation. Transplant International 21:9, pages 916-918.
Crossref
Crossref
Allan D. Kirk. 2008. Kidney Transplantation. Kidney Transplantation
309
332
.
Markus Jensen, Martin Klehr, Anna Vogel, Sandra Schmitz, Samir Tawadros, Martina Mühlenhoff, Anne Plück, Thomas Fischer, Klaus Schomäcker, Joachim L. Schultze & Frank Berthold. (2007) One Step Generation of Fully Chimeric Antibodies Using Cγ1- and Cκ Mutant Mice. Journal of Immunotherapy 30:3, pages 338-349.
Crossref
Crossref
Martin S. Weber & Scott S. Zamvil. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
Mahmoud M. El-Mas, Fouad M. Sharabi, Sahar M. El-gowilly & Mahmoud M. Mohy El-Din. (2007) Inhibition of nitric oxide-guanylate cyclase-dependent and -independent signaling contributes to impairment of ?-adrenergic vasorelaxations by cyclosporine. Biochemical Pharmacology 73:3, pages 359-367.
Crossref
Crossref
V. Moulisová, M. Srbová, O. Jedlicková, J. Šebestian & A. Jegorov. (2006) Silybin reduces lipid peroxidation of rat hepatocyte membrane caused by cyclosporin A. Biochemistry (Moscow) 71:10, pages 1110-1114.
Crossref
Crossref
Juliet C. GrayPeter W. M. JohnsonMartin J. Glennie. (2006) Therapeutic potential of immunostimulatory monoclonal antibodies. Clinical Science 111:2, pages 93-106.
Crossref
Crossref
Lin Yan, Richard Budhu, Pei Huo, Christopher L. Lynch, Jeffrey J. Hale, Sander G. Mills, Richard Hajdu, Carol A. Keohane, Mark J. Rosenbach, James A. Milligan, Gan-Ju Shei, Gary Chrebet, James Bergstrom, Deborah Card & Suzanne M. Mandala. (2006) 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorganic & Medicinal Chemistry Letters 16:13, pages 3564-3568.
Crossref
Crossref
Darrell E. Hurt, Amanda E. Sutton & Jon Clardy. (2006) Brequinar derivatives and species-specific drug design for dihydroorotate dehydrogenase. Bioorganic & Medicinal Chemistry Letters 16:6, pages 1610-1615.
Crossref
Crossref
Hans Lassmann. (2005) Mechanisms of multiple sclerosis. Drug Discovery Today: Disease Mechanisms 2:4, pages 447-452.
Crossref
Crossref
M. Vukmanovic-Stejic, A. McQuaid, K.E. Birch, J.R. Reed, C. Macgregor, M.H.A. Rustin & A.N. Akbar. (2005) Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis. British Journal of Dermatology 153:4, pages 750-757.
Crossref
Crossref
E. Da?browska-Zamojcin, A. Pawlik, L. Doma?ski, J. R??a?ski & M. Dro?dzik. (2005) Cyclosporine and Sirolimus Interaction in a Kidney Transplant Patient. Transplantation Proceedings 37:5, pages 2317-2319.
Crossref
Crossref
Andreas Pascher & Jochen Klupp. (2005) Biologics in the Treatment of Transplant Rejection and Ischemia/Reperfusion Injury. BioDrugs 19:4, pages 211-231.
Crossref
Crossref
Francis J Dumont. (2004) CTLA4-Ig fusion proteins: promise for improved therapy of transplant rejection and autoimmune diseases. Therapy 1:2, pages 289-304.
Crossref
Crossref
Amal G. Omar & Mahmoud M. El-Mas. (2004) Time-Domain Evaluation of Cyclosporine Interaction with Hemodynamic Variability in Rats. Cardiovascular Drugs and Therapy 18:6, pages 461-468.
Crossref
Crossref
I Grossman, N Avidan, C Singer, T Paperna, D Lancet, J S Beckmann & A Miller. (2004) Genomic profiling of interpopulation diversity guides prioritization of candidate-genes for autoimmunity. Genes & Immunity 5:6, pages 493-504.
Crossref
Crossref
Ludwig Kappos, Jens Kuhle, Achim Gass, Lutz Achtnichts & Ernst-Wilhelm Radue. (2004) Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?. Journal of Neurology 251:S5, pages v57-v64.
Crossref
Crossref
Jeffrey J. Hale, George Doherty, Leslie Toth, Sander G. Mills, Richard Hajdu, Carol Ann Keohane, Mark Rosenbach, James Milligan, Gan-Ju Shei, Gary Chrebet, James Bergstrom, Deborah Card, Michael Forrest, Shu-Yu Sun, Sarah West, Huijuan Xie, Naomi Nomura, Hugh Rosen & Suzanne Mandala. (2004) Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists. Bioorganic & Medicinal Chemistry Letters 14:13, pages 3501-3505.
Crossref
Crossref
Jeffrey J. Hale, William Neway, Sander G. Mills, Richard Hajdu, Carol Ann Keohane, Mark Rosenbach, James Milligan, Gan-Ju Shei, Gary Chrebet, James Bergstrom, Deborah Card, Gloria C. Koo, Sam L. Koprak, Jesse J. Jackson, Hugh Rosen & Suzanne Mandala. (2004) Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720. Bioorganic & Medicinal Chemistry Letters 14:12, pages 3351-3355.
Crossref
Crossref
John M. Kovarik, Robert Schmouder, Denise Barilla, Gilles-Jacques Riviere, Yibin Wang & Thomas Hunt. (2004) Multiple-Dose FTY720: Tolerability, Pharmacokinetics, and Lymphocyte Responses in Healthy Subjects. The Journal of Clinical Pharmacology 44:5, pages 532-537.
Crossref
Crossref
R Ferguson. (2004) FTY720 immunomodulation: optimism for improved transplant regimens. Transplantation Proceedings 36:2, pages S549-S553.
Crossref
Crossref
Paul E. Herbert & A.N. Warrens. (2004) Solid Organ and Composite Organ Transplantation - the dynamic equilibrium of rejection and immunosuppression. The Journal of Surgery 2:1, pages 12-14.
Crossref
Crossref